Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis

Multiple Sclerosis Journal - Tập 9 Số 5 - Trang 521-525 - 2003
H. Devilliers1, Christine Lebrun‐Frénay2, Tanya Stojkovic1, D. Ferriby1, M. Chatel2, Patrick Vermersch1
1Department of Neurology, Hôpital R. Salengro, University of Lille, France,
2Department of Neurology, University of Nice, France

Tóm tắt

Devic's neuromyelitis optica (NMO) associates optic neuritis and myelopathy without other neurological signs. Many patients with NMO may be diagnosed as having multiple sclerosis (MS). However, there have been no previous studies comparing these two patho logies and it is still unclear if NMO is a separate entity or a subtype of MS. In the present study, we compared a series of NMO patients with a series of MS patients for whom optic neuritis or myelopathy was the presenting symptom, in order to determine the place of NMO in the spectrum of MS. We retrospectively studied 30 patients diagnosed with NMO and we compared these patients with 50 consecutive MS cases revealed by optic neuritis or acute myelopathy. MS patients were only included if a relapse occurred demonstrating time and space dissemination. We compared the two groups in terms of clinical presentatio n, laboratory findings (MRI and C SF) and clinical outcome. NMO patients were older and more frequently women than MS patients but the difference was not significant. C SF and MRI data were clearly different: oligoclonal bands (O C B) were found in 23% of NMO cases and 88% of MS (P B/0.001), abnormal brain MRI data were observed in 10% of NMO cases and 66% of MS (P B/0.001) and a large spinal cord lesion was observed in 67% of NMO cases and 7.4% of MS cases (P B/0.001). C linical outcome was evaluated as more severe in the NMO group (P B/0.001). O n the basis of clinical data, all NMO patients but three had dissemination in time and space. When we included MRI parameters, only two of the NMO patients met criteria for MS and one of the MS patients met criteria for NMO. O ur study demonstrates that NMO and MS should be considered as two different entities. The respective criteria for NMO and MS were able to distinguish these two patho logies but only when MRI data were applied. This finding could have implications for future therapeutic trials.

Từ khóa


Tài liệu tham khảo

10.1093/brain/61.4.430

Leys D, 1987, Rev Neurol, 143, 722

10.1002/ana.410340211

10.1136/jnnp.60.4.382

10.1212/WNL.53.5.1107

10.1016/S0022-510X(02)00043-6

10.1093/rheumatology/38.2.191

10.1191/096120399678847696

10.1016/0002-9343(92)90788-D

de Seze J, 2001, Rev Neurol, 157, 669

10.1093/rheumatology/39.2.215

10.1093/brain/120.11.2059

10.1002/ana.410130302

10.1002/ana.1032

10.1212/WNL.33.11.1444

10.1093/brain/112.1.133

10.1007/BF00314631

10.1136/jnnp.57.9.1140

10.1177/135245850000600503

10.1136/jnnp.60.5.572

10.1034/j.1600-0404.2000.102005322.x

McLean BN, 1990, Brain, 113, 1269, 10.1093/brain/113.5.1269

10.1212/WNL.53.8.1705

10.1093/brain/124.8.1509

10.1212/WNL.48.1.58

10.1093/brain/124.3.493

10.1093/brain/awf151

Weinchenker BG, 2003, Neurology, 60, A520, 10.1212/WNL.60.3.520

10.1016/S0387-7604(01)00256-X

10.1212/WNL.51.4.1219

Thông tin
Thông tin xuất bản

Multiple Sclerosis Journal

Tập 9 Số 5

521-525

Thông tin tác giả